BRIEF-Frazier Life Sciences reports 15.8 pct stake in Alpine Immune Sciences

* Frazier Life Sciences reports 15.8 percent stake in Alpine Immune Sciences as of July 24, 2017 - SEC filing Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.